• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人季节性 H3N2 流感神经氨酸酶的抗原进化受到电荷平衡的限制。

Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing.

机构信息

Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, United States.

Department of Physics, University of Washington, Seattle, United States.

出版信息

Elife. 2021 Dec 8;10:e72516. doi: 10.7554/eLife.72516.

DOI:10.7554/eLife.72516
PMID:34878407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8683081/
Abstract

As one of the main influenza antigens, neuraminidase (NA) in H3N2 virus has evolved extensively for more than 50 years due to continuous immune pressure. While NA has recently emerged as an effective vaccine target, biophysical constraints on the antigenic evolution of NA remain largely elusive. Here, we apply combinatorial mutagenesis and next-generation sequencing to characterize the local fitness landscape in an antigenic region of NA in six different human H3N2 strains that were isolated around 10 years apart. The local fitness landscape correlates well among strains and the pairwise epistasis is highly conserved. Our analysis further demonstrates that local net charge governs the pairwise epistasis in this antigenic region. In addition, we show that residue coevolution in this antigenic region is correlated with the pairwise epistasis between charge states. Overall, this study demonstrates the importance of quantifying epistasis and the underlying biophysical constraint for building a model of influenza evolution.

摘要

作为主要的流感抗原之一,H3N2 病毒的神经氨酸酶(NA)由于持续的免疫压力而经历了广泛的进化。尽管 NA 最近已成为一种有效的疫苗靶点,但 NA 抗原进化的生物物理限制在很大程度上仍难以捉摸。在这里,我们应用组合诱变和下一代测序来描述在相隔约 10 年分离的六个不同的人类 H3N2 株中 NA 的抗原区域中的局部适应性景观。局部适应性景观在株间很好地相关,并且成对的上位性高度保守。我们的分析进一步表明,局部净电荷控制着这个抗原区域中的成对上位性。此外,我们表明,这个抗原区域中残基的共进化与电荷状态之间的成对上位性相关。总的来说,这项研究表明了量化上位性和潜在的生物物理限制对于建立流感进化模型的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/f1e7f5b07716/elife-72516-fig5-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/525f14dd2ab4/elife-72516-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/db7fc07dc992/elife-72516-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/aa309593473d/elife-72516-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/5a8bbafe71f6/elife-72516-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/584699a2d0ad/elife-72516-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/909d059143ed/elife-72516-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/9bab74e2a9cb/elife-72516-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/3291505a59ad/elife-72516-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/aab4a0f28000/elife-72516-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/fce9d0ed02f4/elife-72516-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/585d6981501f/elife-72516-fig3-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/d002718660ad/elife-72516-fig3-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/31220c7a1a70/elife-72516-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/1fef9e50907c/elife-72516-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/87fbae869288/elife-72516-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/01ce7feb883c/elife-72516-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/4f8fcdc80c74/elife-72516-fig4-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/f6277aaa773e/elife-72516-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/e351a1f608ef/elife-72516-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/417b830455bf/elife-72516-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/d4a3db295f11/elife-72516-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/be7b8b7d8a33/elife-72516-fig5-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/128e25c49bb1/elife-72516-fig5-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/f1e7f5b07716/elife-72516-fig5-figsupp6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/525f14dd2ab4/elife-72516-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/db7fc07dc992/elife-72516-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/aa309593473d/elife-72516-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/5a8bbafe71f6/elife-72516-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/584699a2d0ad/elife-72516-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/909d059143ed/elife-72516-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/9bab74e2a9cb/elife-72516-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/3291505a59ad/elife-72516-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/aab4a0f28000/elife-72516-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/fce9d0ed02f4/elife-72516-fig3-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/585d6981501f/elife-72516-fig3-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/d002718660ad/elife-72516-fig3-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/31220c7a1a70/elife-72516-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/1fef9e50907c/elife-72516-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/87fbae869288/elife-72516-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/01ce7feb883c/elife-72516-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/4f8fcdc80c74/elife-72516-fig4-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/f6277aaa773e/elife-72516-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/e351a1f608ef/elife-72516-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/417b830455bf/elife-72516-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/d4a3db295f11/elife-72516-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/be7b8b7d8a33/elife-72516-fig5-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/128e25c49bb1/elife-72516-fig5-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8683081/f1e7f5b07716/elife-72516-fig5-figsupp6.jpg

相似文献

1
Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing.人季节性 H3N2 流感神经氨酸酶的抗原进化受到电荷平衡的限制。
Elife. 2021 Dec 8;10:e72516. doi: 10.7554/eLife.72516.
2
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.2009 年至 2017 年期间人类流感 N2 神经氨酸酶的抗原景观。
Elife. 2024 May 28;12:RP90782. doi: 10.7554/eLife.90782.
3
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.自 2016 年以来流行的 A(H3N2) 流感病毒的神经氨酸酶与 A/香港/4801/2014 疫苗株在抗原性上有明显差异。
Nat Microbiol. 2019 Dec;4(12):2216-2225. doi: 10.1038/s41564-019-0522-6. Epub 2019 Aug 12.
4
Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.2010-2011 年流感季节安大略省季节性流感 A(H3N2)病毒的遗传特征:抗原位点突变的高流行率。
Influenza Other Respir Viruses. 2014 Mar;8(2):250-7. doi: 10.1111/irv.12219. Epub 2013 Dec 6.
5
Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.美国两种人季节性流感病毒传入后猪流感 A 病毒 N2 神经氨酸酶的进化和抗原性演变。
J Virol. 2021 Sep 27;95(20):e0063221. doi: 10.1128/JVI.00632-21. Epub 2021 Aug 11.
6
Mutational fitness landscape of human influenza H3N2 neuraminidase.人类 H3N2 流感神经氨酸酶的突变适应性景观。
Cell Rep. 2023 Jan 31;42(1):111951. doi: 10.1016/j.celrep.2022.111951. Epub 2023 Jan 5.
7
Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.鉴定和表征 N2 神经氨酸酶上的新型抗体表位。
mSphere. 2021 Feb 10;6(1):e00958-20. doi: 10.1128/mSphere.00958-20.
8
Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase.人类流感 H3N2 神经氨酸酶进化偶然性的流行和机制。
Nat Commun. 2022 Oct 28;13(1):6443. doi: 10.1038/s41467-022-34060-8.
9
Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.美国猪群中流行的 2010.1 年 H3N2 猪流感 A 病毒的当代特征。
Virology. 2021 Jan 15;553:94-101. doi: 10.1016/j.virol.2020.11.006. Epub 2020 Nov 21.
10
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.甲型 H1N1 流感病毒神经氨酸酶抗原漂移导致 A/加利福尼亚/7/2009(H1N1pdm09)特异性抗体效力降低。
mBio. 2019 Apr 9;10(2):e00307-19. doi: 10.1128/mBio.00307-19.

引用本文的文献

1
Eco-evolutionary dynamics of pathogen immune-escape: deriving a population-level phylodynamic curve.病原体免疫逃逸的生态进化动力学:推导群体水平的系统发育动力学曲线。
J R Soc Interface. 2025 Apr;22(225):20240675. doi: 10.1098/rsif.2024.0675. Epub 2025 Apr 2.
2
Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.SARS-CoV-2 突变谱中核衣壳蛋白生物物理特性的调制。
Elife. 2024 Jun 28;13:RP94836. doi: 10.7554/eLife.94836.
3
Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin.

本文引用的文献

1
MAVE-NN: learning genotype-phenotype maps from multiplex assays of variant effect.MAVE-NN:从变异效应的多重分析中学习基因型-表型图谱。
Genome Biol. 2022 Apr 15;23(1):98. doi: 10.1186/s13059-022-02661-7.
2
Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors.病毒糖蛋白及其宿主受体的深度突变扫描
Front Mol Biosci. 2021 Apr 9;8:636660. doi: 10.3389/fmolb.2021.636660. eCollection 2021.
3
Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape.人类 H3N2 流感病毒主要抗原位点 B 具有不断进化的局部适合度景观。
上位性介导了近期人源 H3N2 血凝素受体结合模式的进化。
Nat Commun. 2024 Jun 18;15(1):5175. doi: 10.1038/s41467-024-49487-4.
4
The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.2009 年至 2017 年期间人类流感 N2 神经氨酸酶的抗原景观。
Elife. 2024 May 28;12:RP90782. doi: 10.7554/eLife.90782.
5
Learning the shape of protein microenvironments with a holographic convolutional neural network.用全息卷积神经网络学习蛋白质微环境的形状。
Proc Natl Acad Sci U S A. 2024 Feb 6;121(6):e2300838121. doi: 10.1073/pnas.2300838121. Epub 2024 Feb 1.
6
Modulation of Biophysical Properties of Nucleocapsid Protein in the Mutant Spectrum of SARS-CoV-2.SARS-CoV-2突变谱中核衣壳蛋白生物物理性质的调控
bioRxiv. 2024 Mar 22:2023.11.21.568093. doi: 10.1101/2023.11.21.568093.
7
Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase.流感病毒感染中的免疫反应和病毒神经氨酸酶对免疫损伤的调节。
Virol J. 2023 Aug 28;20(1):193. doi: 10.1186/s12985-023-02164-2.
8
Jointly modeling deep mutational scans identifies shifted mutational effects among SARS-CoV-2 spike homologs.联合建模深度突变扫描可识别严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突同源物之间的突变效应变化。
bioRxiv. 2023 Aug 2:2023.07.31.551037. doi: 10.1101/2023.07.31.551037.
9
Co-evolution of immunity and seasonal influenza viruses.免疫与季节性流感病毒的共同进化。
Nat Rev Microbiol. 2023 Dec;21(12):805-817. doi: 10.1038/s41579-023-00945-8. Epub 2023 Aug 2.
10
Steering and controlling evolution - from bioengineering to fighting pathogens.引导和控制进化——从生物工程到对抗病原体。
Nat Rev Genet. 2023 Dec;24(12):851-867. doi: 10.1038/s41576-023-00623-8. Epub 2023 Jul 3.
Nat Commun. 2020 Mar 6;11(1):1233. doi: 10.1038/s41467-020-15102-5.
4
Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits.在未接种疫苗的新兵中,针对季节性 A/H3N2 爆发的流感,中和抗体和神经氨酸酶抗体与保护作用相关。
Clin Infect Dis. 2020 Dec 15;71(12):3096-3102. doi: 10.1093/cid/ciz1198.
5
Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.人源抗 N9 神经氨酸酶抗体对 H7N9 流感病毒的保护作用的结构基础。
Cell Host Microbe. 2019 Dec 11;26(6):729-738.e4. doi: 10.1016/j.chom.2019.10.002. Epub 2019 Nov 19.
6
Modeling Electrostatic Force in Protein-Protein Recognition.蛋白质-蛋白质识别中静电力的建模
Front Mol Biosci. 2019 Sep 25;6:94. doi: 10.3389/fmolb.2019.00094. eCollection 2019.
7
Evolutionary couplings detect side-chain interactions.进化偶联分析可检测侧链相互作用。
PeerJ. 2019 Jul 8;7:e7280. doi: 10.7717/peerj.7280. eCollection 2019.
8
Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans.全面绘制禽流感聚合酶蛋白 PB2 对人类的适应图谱。
Elife. 2019 Apr 30;8:e45079. doi: 10.7554/eLife.45079.
9
Deep Mutational Scan of the Highly Conserved Influenza A Virus M1 Matrix Protein Reveals Substantial Intrinsic Mutational Tolerance.深度突变扫描高度保守的流感病毒 M1 基质蛋白揭示了大量内在突变容忍性。
J Virol. 2019 Jun 14;93(13). doi: 10.1128/JVI.00161-19. Print 2019 Jul 1.
10
Epistatic interactions can moderate the antigenic effect of substitutions in haemagglutinin of influenza H3N2 virus.上位性相互作用可以调节流感 H3N2 病毒血凝素中替换的抗原效应。
J Gen Virol. 2019 May;100(5):773-777. doi: 10.1099/jgv.0.001263. Epub 2019 Apr 24.